The Anglo-Swedish pharmaceutical giant AstraZeneca faces mounting pressure from shareholders regarding ongoing investigations in China, one of its key markets. The concerns emerged after the detention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback